Skip to main content
OpenTrials

Clinical trial condition

Gastrointestinal Neoplasms

Explore clinical trials studying Gastrointestinal Neoplasms. Study availability and eligibility vary by location and protocol.

80 public trials 14 recruiting studies
Refine in advanced search Browse all conditions

Gastrointestinal Neoplasms trial results

Completed

A Prospective, Multicenter Randomized Controlled Study of the Application of Preoperative FOLFOXIRI Chemotherapy Combined With Lateral Lymph Node Dissection in Low- and Medium-lying Rectal Cancer With Lateral Lymph Node Metastasis

NCT06048146

Conditions
Cancer of Rectum and Anus, Colorectal Neoplasms, Digestive System Diseases, +16 more
Locations
  • Cancer Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College Beijing, Beijing Municipality, China
View Trial Details
Completed

Phase 1/2 Study of the Highly-selective RET Inhibitor, Pralsetinib (BLU-667), in Participants With Thyroid Cancer, Non-Small Cell Lung Cancer, and Other Advanced Solid Tumors

NCT03037385

Conditions
Adenocarcinoma, Adenocarcinoma, Papillary, Bronchial Diseases, +55 more
Locations
  • Mayo Clinic Hospital Phoenix, Arizona, United States
  • UC Irvine Medical Center Orange, California, United States
  • University of Colorado Anschutz Medical Campus Aurora, Colorado, United States
  • Georgetown University Medical Center Washington D.C., District of Columbia, United States
View all 71 locations
View Trial Details
Completed

A Study of IMU-131(HER-Vaxx) and Chemotherapy Compared to Chemotherapy Only in Patients With HER2 Positive Advanced Gastric Cancer

NCT02795988

Conditions
Adenocarcinoma, Carcinoma, Digestive System Diseases, +11 more
Locations
  • ARENSIA Exploratory Medicine LLC Tbilisi, Georgia
  • City Cancer Center Vijayawada, Andhra Pradesh, India
  • North East Cancer Hospital and Research Institute Guwahati, Assam, India
  • Shetty's Hospital Bengaluru, Karnataka, India
View all 22 locations
View Trial Details
Completed

A Study of RGX-202-01 (Ompenaclid) as Combination Therapy in RAS Mutant Advanced Colorectal Cancer

NCT03597581

Conditions
CRC, Colonic Diseases, Colorectal Cancer, +18 more
Locations
  • Arizona Oncology Associates, PC - HAL Prescott Valley, Arizona, United States
  • Arizona Oncology Associates, PC - HOP E Tucson, Arizona, United States
  • Cedars-Sinai Medical Center Los Angeles, California, United States
  • Sharp HealthCare San Diego, California, United States
View all 17 locations
View Trial Details
Completed

A Study to Find a Safe and Effective Dose of BI 905711 in Patients With Advanced Gastrointestinal Cancer

NCT04137289

Conditions
Adenocarcinoma, Carcinoma, Cholangiocarcinoma, +12 more
Locations
  • Yale Cancer Center New Haven, Connecticut, United States
  • Memorial Sloan-Kettering Cancer Center New York, United States
  • The University of Texas MD Anderson Cancer Center Houston, Texas, United States
  • START South Texas Accelerated Research Therapeutics, LLC San Antonio, Texas, United States
View all 18 locations
View Trial Details

Related conditions